The Myasthenia Gravis Rare Disease Network (MGNet) aims to enhance therapeutic development for Myasthenia Gravis (MG) by partnering with academic centers, foundations, other research groups, and industry. Its mission encompasses improving clinical trial tools, finding disease biomarkers for better treatment prediction, educating young investigators on rare diseases, and raising awareness about MG's unique patient needs.
The MGNet Scholar Program aims to fill the critical need for investigators in the field of myasthenia gravis (MG) research, particularly in areas such as clinical research, biomarker development, and research neuroimmunology. It provides mentored research training to prepare scholars for independent research careers. The program offers up to $75,000 per year for up to two years, supporting salary, research costs, and didactics, with an additional $3,000 yearly for travel and skill acquisition. Successful scholars will create a development plan, forming an advisory committee for regular review and approvals for career development activities, with an emphasis on transitioning to further funding opportunities for research and career growth.